Business · 12/07/2019Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Hormonal Contraceptive Drug Products
Summary
The US Food and Drug Administration (FDA) has published a draft guidance document outlining key design considerations for clinical trials of hormonal drug products intended to prevent pregnancy, aiming to facilitate the development of new and improved contraceptive medications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →